Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2218 (LINC02218)

Target
LINC02218
Molecular classification
Long non-coding RNA, Intergenic long non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2218 (LINC02218) is a member of the long intergenic non-coding RNA (lincRNA) family, transcribed from the human chromosome 5 (location: 17,444,010-17,487,371, forward strand)[3]. LincRNAs are a subclass of long non-coding RNAs situated between protein-coding genes; they do not code for proteins but can regulate gene expression at the transcriptional and chromatin levels, often exhibiting tissue specificity[1][7]. LINC02218 is predicted to have roles in transcription coactivation and assembly of the RNA polymerase II preinitiation complex[5], but its specific biological functions, interactions, disease relevance, or therapeutic potential have not yet been described in the published literature as of the current date. There is no evidence that LINC02218 is a direct therapeutic target or involved in any major disease pathway, distinguishing it from some other lincRNAs with established disease associations (such as LINC01116); current knowledge on LINC02218 remains largely at the bioinformatic or annotation level[3][5].

Other names
LINC02218long intergenic non-protein coding RNA 2218
02

Biological functions

Transcriptional regulation (predicted)Chromatin remodeling (by general lincRNA family roles)RNA stabilization (by general lincRNA family roles)Genome architecture modulation (by general lincRNA family roles)Transcription coactivator activity (predicted)RNA polymerase II preinitiation complex assembly (predicted)Other
03

Disease associations

Other (no direct disease association described for LINC02218 as of current sources)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2218 (LINC02218).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2218 (LINC02218).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call